Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis
Bruce Strober, Kim A Papp, Mary Flack, Yihua Gu, Elizabeth HZ Thompson, Wendell C Valdecantos
Abstract Not Available
Disclosures: Study supported by AbbVie.
psoriasis; risankizumab; biologic therapy
Abstract - 199 Poster PDF - 51
- There are currently no refbacks.